Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02054650 · ClinicalTrials.gov registry record · NA
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
A NA study, sponsored by University of North Texas Health Science Center.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02054650 is a NA study that was terminated before completion, run by University of North Texas Health Science Center. The registered enrollment target is 23 participants.
The verdict
NCT02054650, a NA study, was terminated before completion, sponsored by University of North Texas Health Science Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The study hypothesis is based on osteopathic medical philosophy that: 1) the body is a unit; 2) the body has inherent self-regulatory mechanisms; 3) structure and function are interrelated; and 4) rational treatment is based on an understanding and integration of these concepts. Patients with type 2 diabetes mellitus often report more aches and pains than people without diabetes. Because osteopathic manual medicine addresses dysfunction in the musculoskeletal system, patients with both chronic low back pain and type 2 diabetes mellitus may benefit from this non-pharmacological treatment to reduce their pain, thereby reducing their stress and perhaps providing better clinical control for diabetes as demonstrated by key markers such as hemoglobin A1c and kidney function. This study is an extension of research completed in the OSTEOPATHIC Trial. Results of that study were published in the Annals of Family Medicine in March/April 2013.
Interventions
- OTHER Osteopathic Manual Treatment (OMT)
- OTHER Sham OMT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02054650
The ClinicalTrials.gov registry entry for NCT02054650 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Texas Health Science Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Osteopathic Manual Treatment (OMT) is the first listed.
NCT02054650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02054650 about?
NCT02054650 is a clinical study titled "OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus". The study hypothesis is based on osteopathic medical philosophy that: 1) the body is a unit; 2) the body has inherent self-regulatory mechanisms; 3) structure and function are interrelated; and 4) rational treatment is based on an understanding and integration of these concepts. Patients with type 2...
What is the current status of trial NCT02054650?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2014-05. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02054650?
The interventions under investigation include: Osteopathic Manual Treatment (OMT) (OTHER), Sham OMT (OTHER).
Who is sponsoring clinical trial NCT02054650?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.